India to Comoro Islands Pharmaceutical Export (2026) — $62.7K, 7 Suppliers | TransData Nexus

India to Comoro Islands Pharmaceutical Export (2026) — $62.7K, 7 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Comoro Islands

#	Formulation	Value	Share
1	Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine 10 Dose Vial…	$17.0K	27.2%
2	Harmless Pharmaceutical Medicines Finished Formulation Multiscot Syrup Health S…	$9.6K	15.3%
3	Pharmaceuticals Products, Tablets Tramadol Hydrochloride B.p 225mg,,b/n.ot-2411…	$7.1K	11.3%
4	Haemaccel 500ml, Bt No#ha4017, Mfg#11/2024, Exp#10/2027	$5.9K	9.4%
5	Contains Medicines Harmless Pharmaceutical Product Details As Per Attached Expo…	$4.4K	7.0%
6	Phenobarbitone Sodium Injection 1ml	$4.4K	7.0%
7	Drugs and Pharmaceuticals Harmlessmedicines Rifampicin Capsules BP 150 MG	$3.8K	6.0%
8	Pharmaceutical Medicine for Human Use: Harmiess Mediclne for Human Diazepam Inj…	$3.8K	6.0%
9	Quinine Dihydrochloride Injection 300mg/ml, 2ml Batch No.9q25001,d/mfg.01/2025,…	$3.5K	5.6%
10	Nicardipine Hydrochloride Injection Uspbatch No.ga24l-89a,d/mfg.12/2024, D/exp.…	$3.0K	4.8%
11	Sodium Valproate Gastro Resistant Tablets I.p 500mg Batch No.spt250662,d/mfg.03…	$242	0.4%

India exports 11+ pharmaceutical formulations to Comoro Islands with a combined trade value of $62.7K. Key products include Sodium ($4K), Quinine ($3K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 15 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Comoro Islands Trade Routes

1Sodium$4K

2Quinine$3K

These are the top pharmaceutical products exported from India to Comoro Islands, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Comoro Islands buyers, regulatory requirements, and logistics for that specific product corridor. Products include Sodium ($4K), Quinine ($3K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Comoro Islands

1Biological E. Limited

$17K

2Sidhaant Life Sciences Private Limited

$13K

3Scott Edil Pharmacia Limited

$10K

4Fedelty Healthcare Private Limited

$9K

5Oshin Laboratories Private Limited

Port Analysis — India to Comoro Islands Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)33.3%

NHAVA SHEVA SEA (INNSA1)40.0%

DELHI AIR CARGO ACC (INDEL4)26.7%

Comoro Islands Import Ports

MORONI53.3%

MORONI, PRINCE SAID26.7%

Moroni20.0%

Trade Statistics

Total Value$63K

Shipments15

Indian Exporters7

Comoro Islands Buyers7

Avg Shipment$4K

Products11

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Comoro Islands Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the Comoro Islands has experienced gradual growth over the past decade. In 2023, Comoros imported pharmaceutical products valued at approximately $1.54 million from India, marking a steady increase from previous years. This upward trajectory reflects India's expanding role as a key supplier of pharmaceutical formulations to the Comoro Islands. The trade encompasses a diverse range of finished pharmaceutical products, including tablets, capsules, syrups, and injections, catering to the healthcare needs of the Comorian population.

2India's Market Position

India holds a significant position in the Comoro Islands' pharmaceutical import market. In 2023, Indian pharmaceutical exports to Comoros were valued at $1.54 million, contributing to a substantial portion of the country's total pharmaceutical imports. This underscores India's strategic importance as a reliable supplier of high-quality, cost-effective pharmaceutical products to the Comoro Islands.

3Recent Developments

Between 2024 and 2026, the India-Comoro Islands pharmaceutical trade witnessed notable developments. In November 2025, Comoros updated its import licensing procedures, enhancing the regulatory framework for pharmaceutical imports. These changes aim to streamline the registration and approval processes, potentially facilitating smoother trade relations between the two nations. Additionally, ongoing diplomatic engagements have focused on strengthening bilateral trade ties, with discussions emphasizing the importance of pharmaceutical exports in enhancing healthcare access in the Comoro Islands.

Comoro Islands Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export products to the Comoro Islands must adhere to the guidelines set by the Agence Comorienne de la Sécurité Sanitaire et de l’Environnement (ACSSE), the regulatory authority overseeing medicine registration and imports. The registration process involves submitting a comprehensive dossier that includes product information, manufacturing details, and quality control data. Compliance with the Common Technical Document (CTD) format is typically required, ensuring consistency and clarity in submissions. The ACSSE evaluates these dossiers to ensure that imported pharmaceutical products meet the necessary safety, efficacy, and quality standards. The timeline for registration can vary, but efficient preparation and submission of the required documentation can expedite the process.

2GMP & Facility Requirements

The Comoro Islands mandates that pharmaceutical products imported into the country be manufactured in facilities compliant with Good Manufacturing Practice (GMP) standards. Indian manufacturers exporting to Comoros must ensure that their production sites adhere to these standards, which encompass quality management, personnel qualifications, sanitation, and equipment maintenance. The ACSSE conducts inspections to verify GMP compliance, and mutual recognition agreements may facilitate the acceptance of certifications from recognized authorities, such as the World Health Organization (WHO). Maintaining up-to-date certifications and a robust quality assurance system is crucial for Indian exporters to maintain uninterrupted access to the Comorian market.

3Import Documentation

To import pharmaceutical products into the Comoro Islands, Indian exporters must provide specific documentation to comply with ACSSE regulations. Essential documents include the Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of GMP compliance. These documents substantiate the quality and safety of the pharmaceutical products. Additionally, import licenses are required, and customs procedures must be followed to ensure the smooth clearance of goods. Staying informed about any updates to import regulations and maintaining accurate and complete documentation are vital for successful market entry and sustained trade relations.

TransData Nexus Research · Comoro Islands regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Comoro Islands

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to the Comoro Islands are predominantly composed of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. These products align with the Comoro Islands' healthcare needs, addressing prevalent conditions such as infectious diseases, pain management, and chronic illnesses. The demand for these formulations is driven by the necessity to provide accessible and effective medical treatments to the Comorian population. The therapeutic areas covered by these exports are critical in enhancing the overall health standards and combating prevalent health challenges within the islands.

2Emerging Opportunities

The evolving healthcare landscape in the Comoro Islands presents emerging opportunities for Indian pharmaceutical exporters. The Comorian government is focusing on expanding healthcare access and improving disease management, creating a favorable environment for the introduction of new therapeutic areas. Indian exporters can explore opportunities in areas such as oncology, cardiology, and diabetes management, where there is a growing need for specialized treatments. Additionally, the demand for biosimilars is on the rise, offering a cost-effective alternative to expensive biologic therapies. By aligning their product portfolios with these emerging needs, Indian pharmaceutical companies can strengthen their presence in the Comorian market.

3Demand Drivers

The demand for pharmaceutical imports in the Comoro Islands is influenced by several factors. The country's disease burden, including high rates of infectious diseases and chronic conditions, necessitates a continuous supply of medical treatments. An aging population further contributes to the increased need for healthcare services and pharmaceutical products. Moreover, trends in healthcare spending indicate a growing investment in health infrastructure and services, which drives the import demand for quality pharmaceutical products. These factors collectively create a robust market for Indian pharmaceutical exports to the Comoro Islands.

TransData Nexus Research · DGFT trade data analysisMar 2026

Supply Chain & Logistics — India to Comoro Islands Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical products from India to the Comoro Islands are typically shipped via sea routes, with major ports in India such as Nhava Sheva Sea (INNSA1) and Sahar Air Cargo Acc (INBOM4) serving as primary export points. The transit time for sea shipments is approximately 10-14 days, depending on the specific route and shipping conditions. Air shipments, though less common, offer faster delivery times, typically ranging from 3-5 days. Exporters should monitor potential disruptions in key maritime routes, such as the Red Sea, which could impact delivery schedules. Maintaining flexibility and having contingency plans in place are essential for ensuring timely deliveries.

2Port Infrastructure

In India, key export ports include Sahar Air Cargo Acc (INBOM4), Nhava Sheva Sea (INNSA1), and Delhi Air Cargo Acc (INDEL4), which collectively handle a significant portion of pharmaceutical exports. In the Comoro Islands, primary import ports are Moroni, Moroni Prince Said, and Moroni Port, which manage the majority of incoming pharmaceutical shipments. Understanding the capabilities and facilities of these ports is crucial for efficient logistics planning and to ensure compliance with import regulations.

3Cold Chain & Compliance

Maintaining the integrity of pharmaceutical products during transit is paramount, especially for temperature-sensitive items. Indian exporters must ensure that their logistics partners provide temperature-controlled shipping solutions that comply with Good Distribution Practice (GDP) standards. This includes using appropriate packaging materials, monitoring devices, and selecting shipping routes that minimize exposure to temperature fluctuations. Adhering to these standards ensures product efficacy upon arrival and aligns with the regulatory requirements of the Comoro Islands.

TransData Nexus Research · DGFT port data, shipping intelligenceMar 2026

FAQ — India to Comoro Islands Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Comoro Islands?

India exported pharmaceuticals worth $62.7K to Comoro Islands across 15 verified shipments.

Who are the top Indian pharmaceutical exporters to Comoro Islands?

1. BIOLOGICAL E. LIMITED — $17.0K. 2. SIDHAANT LIFE SCIENCES PRIVATE LIMITED — $12.6K. 3. SCOTT EDIL PHARMACIA LIMITED — $9.6K. Total: 7 suppliers.

Which companies in Comoro Islands import pharmaceuticals from India?

1. COORDINATION NATIONALE DU PEV VIA — $17.0K. 2. OFFICE COMORIEN DES PRODUITS — $12.6K. 3. TO THE DIRECTOR — $9.6K. 7 buyers total.

What pharmaceutical products does India export most to Comoro Islands?

1. Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine 10 Dose Vial… ($17.0K, 27.2%); 2. Harmless Pharmaceutical Medicines Finished Formulation Multiscot Syrup Health S… ($9.6K, 15.3%); 3. Pharmaceuticals Products, Tablets Tramadol Hydrochloride B.p 225mg,,b/n.ot-2411… ($7.1K, 11.3%); 4. Haemaccel 500ml, Bt No#ha4017, Mfg#11/2024, Exp#10/2027 ($5.9K, 9.4%); 5. Contains Medicines Harmless Pharmaceutical Product Details As Per Attached Expo… ($4.4K, 7.0%)

Which ports handle pharmaceutical shipments from India to Comoro Islands?

Export: SAHAR AIR CARGO ACC (INBOM4), NHAVA SHEVA SEA (INNSA1), DELHI AIR CARGO ACC (INDEL4). Import: MORONI, MORONI, PRINCE SAID, Moroni.

Why does Comoro Islands import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $62.7K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Comoro Islands?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Comoro Islands pharmaceutical trade?

$4.2K per consignment across 15 shipments.

How many Indian pharmaceutical companies export to Comoro Islands?

7 Indian companies. Largest: BIOLOGICAL E. LIMITED with $17.0K.

How can I find verified Indian pharmaceutical suppliers for Comoro Islands?

TransData Nexus covers 7 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Comoro Islands identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 15 verified shipments from 7 Indian exporters to 7 Comoro Islands buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

7 Exporters

7 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Comoro Islands Pharmaceutical Export